Arincof

Arincof is a combination expectorant syrup developed and marketed by KCC Pharmaceuticals, primarily indicated for the symptomatic relief of cough and congestion associated with the common cold and upper respiratory tract infections. The formulation typically includes diphenhydramine hydrochloride, an H1-receptor antagonist that provides antitussive and antihistaminic effects; ammonium chloride, which acts as an expectorant by irritating the gastric mucosa to reflexively increase respiratory tract fluid; and sodium citrate, which serves as a mucolytic to thin bronchial secretions. This multi-ingredient approach aims to facilitate the expulsion of phlegm while reducing cough frequency and allergic symptoms.

Brand names

ArincofArincof Syrup

Other names

Arincof Expectorant